Privia Health Group, Inc.
PRVA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $1,736 | $1,658 | $1,357 | $966 |
| % Growth | 4.7% | 22.2% | 40.4% | – |
| Cost of Goods Sold | $1,560 | $1,496 | $1,222 | $903 |
| Gross Profit | $177 | $162 | $135 | $64 |
| % Margin | 10.2% | 9.7% | 9.9% | 6.6% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $126 | $110 | $130 | $256 |
| SG&A Expenses | $153 | $134 | $149 | $279 |
| Sales & Mktg Exp. | $26 | $25 | $20 | $23 |
| Other Operating Expenses | $7 | $7 | $5 | $2 |
| Operating Expenses | $160 | $141 | $154 | $281 |
| Operating Income | $17 | $21 | -$19 | -$217 |
| % Margin | 1% | 1.2% | -1.4% | -22.5% |
| Other Income/Exp. Net | $11 | $8 | $1 | -$1 |
| Pre-Tax Income | $28 | $29 | -$19 | -$219 |
| Tax Expense | $11 | $8 | -$7 | -$28 |
| Net Income | $14 | $23 | -$9 | -$188 |
| % Margin | 0.8% | 1.4% | -0.6% | -19.5% |
| EPS | 0.12 | 0.2 | -0.11 | -1.77 |
| % Growth | -40% | 281.8% | 93.8% | – |
| EPS Diluted | 0.11 | 0.19 | -0.11 | -1.77 |
| Weighted Avg Shares Out | 119 | 117 | 111 | 108 |
| Weighted Avg Shares Out Dil | 126 | 125 | 111 | 108 |
| Supplemental Information | – | – | – | – |
| Interest Income | $11 | $8 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $1 |
| Depreciation & Amortization | $7 | $7 | $5 | $2 |
| EBITDA | $24 | $27 | -$15 | -$215 |
| % Margin | 1.4% | 1.6% | -1.1% | -22.2% |